Cosciens Biopharma Q3 EPS $(3.45) Down From $(1.72) YoY, Sales $2.516M Up From $1.476M YoY

Cosciens Biopharma (TSX:CSCI) reported quarterly losses of $(3.45) per share. This is a 100.58 percent decrease over losses of $(1.72) per share from the same period last year. The company reported $2.516 million in sales this quarter. This is a 70.46 percent increase over sales of $1.476 million the same period last year.